<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Avacta shares surge on COVID-19 treatment progress	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/avacta-shares-surge-on-covid-19-treatment-progress/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/avacta-shares-surge-on-covid-19-treatment-progress/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Fri, 05 Jun 2020 09:43:56 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
	<item>
		<title>
		By: Avacta fundraising signals progress towards transformational COVID-19 testing - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/avacta-shares-surge-on-covid-19-treatment-progress/#comment-15367</link>

		<dc:creator><![CDATA[Avacta fundraising signals progress towards transformational COVID-19 testing - UK Investor Magazine]]></dc:creator>
		<pubDate>Fri, 05 Jun 2020 09:43:56 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=28879#comment-15367</guid>

					<description><![CDATA[[&#8230;] Avacta raised £48 million at 120p, representing a 4.4% discount to 125.3p, the 30 day volume weighted average price (VWAP) to 3rd June. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Avacta raised £48 million at 120p, representing a 4.4% discount to 125.3p, the 30 day volume weighted average price (VWAP) to 3rd June. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: FTSE 100 breaks losing streak &#8211; BlackRock UK Management		</title>
		<link>https://ukinvestormagazine.co.uk/avacta-shares-surge-on-covid-19-treatment-progress/#comment-15236</link>

		<dc:creator><![CDATA[FTSE 100 breaks losing streak &#8211; BlackRock UK Management]]></dc:creator>
		<pubDate>Fri, 15 May 2020 21:10:14 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=28879#comment-15236</guid>

					<description><![CDATA[[&#8230;] was also good news in the fight against COVID-19 from the UK’s small caps as&#160;Avacta announced progress in the development&#160;of a potential treatment. Their Affirmer technology has been found to show promising signs in [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] was also good news in the fight against COVID-19 from the UK’s small caps as&nbsp;Avacta announced progress in the development&nbsp;of a potential treatment. Their Affirmer technology has been found to show promising signs in [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
